159 related articles for article (PubMed ID: 7481248)
1. [The treatment of deep venous thrombosis with low-molecular-weight heparin].
Samama MM; Achkar A; Horellou MH
Rev Med Brux; 1995; 16(4):304-9. PubMed ID: 7481248
[TBL] [Abstract][Full Text] [Related]
2. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
3. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
4. The optimal long-term treatment of venous thromboembolism.
Prandoni P
Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
[No Abstract] [Full Text] [Related]
5. Treatment of venous thrombosis.
Lee AY
Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
[No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
Hull RD; Pineo GF
Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
[No Abstract] [Full Text] [Related]
7. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
Brewer D
Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
[No Abstract] [Full Text] [Related]
8. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
Couturaud F; Julian JA; Kearon C
Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
[TBL] [Abstract][Full Text] [Related]
9. Guideline update. VTE disease: which agents, and when.
Holten KB; Merok J
J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
[No Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
11. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
Hirsh J
Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic venous thrombosis. Long-term anticoagulation therapy? Yes.
Haas S
Hamostaseologie; 2006 Jan; 26(1):48-51. PubMed ID: 16444322
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
14. Current and potential uses of low molecular weight heparin: a review and an economic analysis.
Seo P; Locke CF
Am J Manag Care; 2000 Apr; 6(4):498-506; quiz 507-8. PubMed ID: 10977456
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
16. The status of new anticoagulants.
Bates SM; Weitz JI
Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Fiessinger JN
Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
[TBL] [Abstract][Full Text] [Related]
18. [Heparins and curative treatment of venous thromboembolic disease: meta-analysis].
Mismetti P; Laporte-Simitsidis S; Leizorovicz A; Decousus H
Therapie; 1997; 52(1):47-52. PubMed ID: 9183922
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
20. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
Hirsh J
Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
